Impact of Bright Light Therapy on Prader-Willi Syndrome
Recruiting · NCT05939453 · Interventional (participants receive a specific treatment) · Lead sponsor: Maimonides Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
Bright Light TherapySham Light
What this trial is about
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
Who can take part
Age range
6 Years to 88 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of PWS confirmed by genetic testing
- Score of 12 or above on the Epworth Sleepiness Scale (ESS).
Exclusion criteria
- Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications
- A history of previous treatment with LT
- Patients presenting with active psychosis or mania
Where it is running
1 location listed across 1 US state.
- Maimonides Medical Center - Brooklyn, New York, United States